BTW
TMO icon

Boston Trust Walden’s Thermo Fisher Scientific TMO Stock Holding History

Boston Trust Walden’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8M Sell
59,463
-309
-0.5% -$148K 0.23% 150
2026
Q1 		$29.4M Buy
59,772
+15,799
+36% +$8.57M 0.24% 147
2025
Q4 		$25.5M Buy
43,973
+3,873
+10% +$2.19M 0.19% 167
2025
Q3 		$19.4M Buy
40,100
+37,578
+1,490% +$17.5M 0.14% 178
2025
Q2 		$1.02M Buy
2,522
+471
+23% +$197K 0.01% 276
2025
Q1 		$1.02M Hold
2,051
– – 0.01% 277
2024
Q4 		$1.07M Sell
2,051
-34
-2% -$18.7K 0.01% 278
2024
Q3 		$1.29M Buy
2,085
+26
+1% +$15.4K 0.01% 272
2024
Q2 		$1.14M Sell
2,059
-44
-2% -$25.2K 0.01% 274
2024
Q1 		$1.22M Sell
2,103
-52
-2% -$29.2K 0.01% 270
2023
Q4 		$1.14M Buy
2,155
+28
+1% +$13.6K 0.01% 274
2023
Q3 		$1.08M Hold
2,127
– – 0.01% 272
2023
Q2 		$1.11M Buy
2,127
+195
+10% +$105K 0.01% 273
2023
Q1 		$1.11M Hold
1,932
– – 0.01% 273
2022
Q4 		$1.06M Buy
1,932
+651
+51% +$345K 0.01% 280
2022
Q3 		$650K Hold
1,281
– – 0.01% 287
2022
Q2 		$696K Buy
1,281
+9
+0.7% +$4.95K 0.01% 290
2022
Q1 		$751K Hold
1,272
– – 0.01% 293
2021
Q4 		$849K Buy
1,272
+170
+15% +$106K 0.01% 294
2021
Q3 		$630K Buy
1,102
+69
+7% +$37.9K 0.01% 309
2021
Q2 		$521K Hold
1,033
– – ﹤0.01% 323
2021
Q1 		$471K Hold
1,033
– – ﹤0.01% 322
2020
Q4 		$481K Buy
1,033
+50
+5% +$23.4K 0.01% 319
2020
Q3 		$434K Sell
983
-39
-4% -$16.1K 0.01% 320
2020
Q2 		$370K Hold
1,022
– – 0.01% 327
2020
Q1 		$290K Sell
1,022
-123
-11% -$38.8K ﹤0.01% 328
2019
Q4 		$372K Buy
1,145
+112
+11% +$34K ﹤0.01% 343
2019
Q3 		$301K Hold
1,033
– – ﹤0.01% 349
2019
Q2 		$303K Buy
1,033
+14
+1% +$3.86K ﹤0.01% 350
2019
Q1 		$279K Buy
+1,019
New +$254K ﹤0.01% 358
2018
Q4 		– Sell
-833
Closed -$203K – 383
2018
Q3 		$203K Buy
+833
New +$192K ﹤0.01% 376
2018
Q2 		– Sell
-2,233
Closed -$461K – 382
2018
Q1 		$461K Sell
2,233
-430
-16% -$90.3K 0.01% 341
2017
Q4 		$506K Hold
2,663
– – 0.01% 335
2017
Q3 		$504K Sell
2,663
-45
-2% -$8.15K 0.01% 337
2017
Q2 		$472K Sell
2,708
-75
-3% -$12.6K 0.01% 336
2017
Q1 		$427K Buy
2,783
+45
+2% +$6.88K 0.01% 324
2016
Q4 		$386K Sell
2,738
-130
-5% -$19.2K 0.01% 323
2016
Q3 		$456K Sell
2,868
-25
-0.9% -$3.85K 0.01% 315
2016
Q2 		$427K Buy
2,893
+376
+15% +$55.5K 0.01% 318
2016
Q1 		$356K Sell
2,517
-225
-8% -$30.2K 0.01% 326
2015
Q4 		$389K Sell
2,742
-50
-2% -$6.67K 0.01% 320
2015
Q3 		$341K Hold
2,792
– – 0.01% 334
2015
Q2 		$362K Sell
2,792
-250
-8% -$32.6K 0.01% 325
2015
Q1 		$409K Hold
3,042
– – 0.01% 317
2014
Q4 		$381K Sell
3,042
-50
-2% -$6.08K 0.01% 324
2014
Q3 		$376K Buy
3,092
+117
+4% +$14.2K 0.01% 316
2014
Q2 		$351K Hold
2,975
– – 0.01% 315
2014
Q1 		$358K Sell
2,975
-150
-5% -$17.8K 0.01% 293
2013
Q4 		$348K Hold
3,125
– – 0.01% 302
2013
Q3 		$288K Sell
3,125
-500
-14% -$45.2K ﹤0.01% 303
2013
Q2 		$307K Buy
+3,625
New +$302K 0.01% 294

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Boston Trust Walden's TMO Position: Q2 2026 in Review

Boston Trust Walden reduced its Thermo Fisher Scientific (TMO) stake by 0.52% in Q2 2026, selling an estimated $148K and leaving 59,463 shares worth $29.8M. The position accounts for 0.23% of the portfolio, ranked #150.

Boston Trust Walden first reported a position in TMO in Q2 2013 and has held it in 51 quarters since. 1,058 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Boston Trust Walden held 59,463 shares of Thermo Fisher Scientific worth $29.8M as of Q2 2026.
  • Boston Trust Walden sold 309 Thermo Fisher Scientific shares in Q2 2026, an estimated $148K.
  • Thermo Fisher Scientific made up 0.23% of Boston Trust Walden's portfolio in Q2 2026, its #150 holding.
  • Boston Trust Walden first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 51 quarters since.
  • 1,058 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.